Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy's latest financial results aren't sitting well with shareholders.

Why Canopy Growth Stock Is Sinking Today

Roundhill Cannabis ETF

Canopy Growth Corporation (NASDAQ:CGC ) Q1 2023 Earnings Conference Call August 5, 2022 10:00 AM ET Company Participants Tyler Burns - Director of Investor Relations David Klein - Chief Executive Officer Judy Hong - Chief Financial Officer Conference Call Participants Pablo Zuanic - Cantor Fitzgerald Tamy Chen - BMO Capital Markets Victor Ma - Cowen & Co. Andrew Carter - Stifel Aaron Grey - Alliance Global Partners Glenn Mattson - Ladenburg Matt Bottomley - Canaccord Genuity John Zamparo - CIBC Michael Lavery - Piper Sandler Operator Good morning. My name is Grant, I will be your conference operator today.

Canopy Growth Corporation (CGC) CEO David Klein on Q1 2023 Results - Earnings Call Transcript

Flora Growth Corp

GrowGeneration Corp

High Tide

Innovative Industrial Properties

Scotts Miracle-Gro

Tilray Brands

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.

7 Cannabis Stocks Kicking Off August With Some Heat

Canopy Growth Corp. CGC, -1.03% WEED, -1.60% shares fell 6% in premarket trades Friday after the company said it lost C$2.08 billion ($1.61 billion), or $5.23 a share in its fiscal first quarter, compared to a profit of C$392.42 million, or C$1.02 a share, in the year-ago period. The loss was driven by a non-cash, C$1.73 billion goodwill impairment.

Canopy Growth swings to big loss as revenue falls 19%

Canada's Canopy Growth Corp reported a quarterly loss on Friday, as the cannabis producer incurred an impairment charge of C$1.72 billion ($1.33 billion) related to its operations.

Pot producer Canopy Growth posts large loss on impairment charge

Continued progress of premiumization strategy and record quarter from BioSteel accelerating path to profitability  SMITHS FALLS, ON , August 5, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today announces its financial results for the first quarter ended June 30, 2022. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.

Canopy Growth Corporation Reports First Quarter Fiscal Year 2023 Financial Results

Marijuana stock's performance is often subject to what is happening in the cannabis industry.

Major marijuana stocks lost 77% of market cap in last 12 months

Canopy Growth (CGC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Is a Surprise Coming for Canopy Growth (CGC) This Earnings Season?

DraftKings

Western Digital

The three major U.S. equity indexes closed lower Tuesday. The Dow Jones industrials dropped 1.23%, the S&P 500 slipped by 0.67%, and the Nasdaq dipped by 0.16%.

Earnings Previews: Canopy Growth, DraftKings, Western Digital

Cronos Group

Following a rough first half of the year, cannabis stocks are finally enjoying some positive momentum. Key players Tilray (NASDAQ: TLRY ), Canopy Growth (NASDAQ: CGC ) and Cronos (NASDAQ: CRON ) are finally gaining significant ground.

Why Are Cannabis Stocks TLRY, CGC, CRON Up Today?

OrganiGram Holdings Inc.

The Valens Co

Aurora Cannabis

Curaleaf Holdings, Inc.

Chicago Atlantic Real Estate Finance

Constellation Brands

Happy to have Alan Brochstein back! Thoughts on the recent rally (less about Bulls buying than Bears covering), political doubts and overall optimism.

Don't Rule Out A Bull Market (Podcast Transcript)

Does a small turnaround in marijuana sales justify a big jump in marijuana stock prices?

Why Tilray, Canopy, and Aurora Cannabis Just Popped

Gedeon's demonstrated cannabis and commercial expertise will further Canopy Growth's Strategy for North American Cannabis Leadership SMITHS FALLS, ON , Aug. 2, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, hemp, and cannabis device company, is pleased to announce that the appointment of Christelle Gedeon, Ph.D., as the Company's new Chief Legal Officer.

Canopy Growth Announces Industry Veteran Christelle Gedeon As New Chief Legal Officer

The cannabis company reports its earnings on Aug. 5.

3 Burning Questions for Canopy Growth

2 Marijuana Stocks To Buy This August? The post 2 Marijuana Stocks To Watch First Week Of August appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Marijuana Stocks To Watch First Week Of August

HEXO Corp

InMed Pharmaceuticals

Lexaria Bioscience

SNDL Inc.

Turning Point Brands

Village Farms International

9 Cannabis Stocks on Fire This Week

Canopy Growth Corporation (CGC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Canopy Growth Corporation (CGC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

New premium flower offerings from 7ACRES and Doja drop in retail locations this summer SMITHS FALLS, ON , July 28, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis and cannabinoid-based consumer product company, today announced several new additions to its premium flower portfolio. Perfect for both staycations and weekends away, the new premium flower offerings from 7ACRES and Doja demonstrate Canopy Growth's commitment to continued innovation and strengthen its leading position in the premium flower category.

CANOPY GROWTH ANNOUNCES NEW PREMIUM FLOWER LINE-UP PERFECT FOR SUMMER STAYCATIONS AND WEEKENDS AWAY

Amplify Alternative Harvest ETF

Amplify US Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

Advisorshares Poseidon Dynamic Cannabis ETF

AXS Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Don't Rule Out A Bull Market

Canopy Growth Corporation has shredded the majority of its value this year. This has led bulls to consider the stock undervalued, while bears point to its perceived fundamental weaknesses.

Canopy Growth Stock Slides, Analysts Divided

Despite having some favorable legislation in the pipeline, cannabis stocks continue to struggle. As we look across the board on Tuesday, Aurora Cannabis (NASDAQ: ACB ) and Canopy Growth (NASDAQ: CGC ) are both down about 5.5%.

Cannabis Stocks ACB, HEXO, CGC, TLRY Slump Despite Senate Meeting

SMITHS FALLS, ON , July 22, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the first quarter fiscal year 2023 ended June 30, 2022 before financial markets open on August 5, 2022. Following the release of its first quarter fiscal year 2023 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO on August 5, 2022, at 10:00 AM ET.

Canopy Growth to Report First Quarter Fiscal 2023 Financial Results on August 5, 2022

Canada's top-tier cannabis stocks are in retreat yet again.

Why Shares of Aurora Cannabis, Canopy Growth, and Sundial Growers Are Sinking Today

Green Thumb Industries Inc.

The Senate decriminalization bill will get a hearing next week, giving hope to frustrated cannabis investors.

Why Canopy Growth, Green Thumb Industries, and Cresco Labs Stocks Skyrocketed Today

Cannabis stocks heating up on Wednesday as investors prepare for a Senate meeting that could introduce a new legalization bill. The post Cannabis Stocks TLRY, CGC, SNDL, GRWG Soar Ahead of Senate Meeting appeared first on InvestorPlace.

Cannabis Stocks TLRY, CGC, SNDL, GRWG Soar Ahead of Senate Meeting

News for Canopy Growth Stock (CGC)